Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meng Ling Moi

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
BMC Infectious Diseases|January 12, 2018
Dengue virus infection-enhancement activity in neutralizing antibodies of healthy adults before dengue season as determined by using FcγR-expressing cellsMinh Huong Phu Ly, Meng Ling Moi, Thi Bich Hau Vu, et al.
BMC Infectious Diseases|May 13, 2020
Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based surveyCo Thach Nguyen, Meng Ling Moi, Thi Quynh Mai Le, et al.
Journal of Virology|August 5, 2016
Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture SystemSyo Nakajima, Koichi Watashi, Hirofumi Ohashi, et al.
The Journal of General Virology|June 20, 2018
A single amino acid substitution in the NS4B protein of Dengue virus confers enhanced virus growth and fitness in human cells in vitro through IFN-dependent host responseThuy Thu Bui, Meng Ling Moi, Takeshi Nabeshima, et al.
Viruses|July 2, 2021
Emergence of a Novel Dengue Virus 3 (DENV-3) Genotype-I Coincident with Increased DENV-3 Cases in Yangon, Myanmar between 2017 and 2019Aung Min Soe, Mya Myat Ngwe Tun, Takeshi Nabeshima, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 20, 2023
Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, VietnamThi Thanh Ngan Nguyen, Ee Mei Choo, Yukio Nakamura, et al.
Ebiomedicine|February 28, 2025
A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunityFernanda Ana-Sosa-Batiz, Shailendra Kumar Verma, Norazizah Shafee, et al.
Japanese Journal of Infectious Diseases|March 28, 2020
An Epidemic of Dengue Virus Serotype-4 during the 2015 - 2017: the Emergence of a Novel Genotype IIa of DENV-4 in the PhilippinesMark Anthony de Vera Luz, Takeshi Nabeshima, Meng Ling Moi, et al.
Japanese Journal of Infectious Diseases|September 3, 2019
An Epidemic of Dengue Virus Serotype-4 during the 2015 - 2017: the Emergence of a Novel Genotype IIa of DENV-4 in the PhilippinesMark Anthony de Vera Luz, Takeshi Nabeshima, Meng Ling Moi, et al.
Virology|January 17, 2021
U.S.-Japan cooperative medical sciences program: 22nd International Conference on Emerging Infectious Diseases in the Pacific RimKristina T Lu, Takuya Yamamoto, David McDonald, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
BMC Infectious Diseases|January 12, 2018
Dengue virus infection-enhancement activity in neutralizing antibodies of healthy adults before dengue season as determined by using FcγR-expressing cellsMinh Huong Phu Ly, Meng Ling Moi, Thi Bich Hau Vu, et al.
BMC Infectious Diseases|May 13, 2020
Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based surveyCo Thach Nguyen, Meng Ling Moi, Thi Quynh Mai Le, et al.
Journal of Virology|August 5, 2016
Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture SystemSyo Nakajima, Koichi Watashi, Hirofumi Ohashi, et al.
The Journal of General Virology|June 20, 2018
A single amino acid substitution in the NS4B protein of Dengue virus confers enhanced virus growth and fitness in human cells in vitro through IFN-dependent host responseThuy Thu Bui, Meng Ling Moi, Takeshi Nabeshima, et al.
Viruses|July 2, 2021
Emergence of a Novel Dengue Virus 3 (DENV-3) Genotype-I Coincident with Increased DENV-3 Cases in Yangon, Myanmar between 2017 and 2019Aung Min Soe, Mya Myat Ngwe Tun, Takeshi Nabeshima, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 20, 2023
Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, VietnamThi Thanh Ngan Nguyen, Ee Mei Choo, Yukio Nakamura, et al.
Ebiomedicine|February 28, 2025
A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunityFernanda Ana-Sosa-Batiz, Shailendra Kumar Verma, Norazizah Shafee, et al.
Japanese Journal of Infectious Diseases|March 28, 2020
An Epidemic of Dengue Virus Serotype-4 during the 2015 - 2017: the Emergence of a Novel Genotype IIa of DENV-4 in the PhilippinesMark Anthony de Vera Luz, Takeshi Nabeshima, Meng Ling Moi, et al.
Japanese Journal of Infectious Diseases|September 3, 2019
An Epidemic of Dengue Virus Serotype-4 during the 2015 - 2017: the Emergence of a Novel Genotype IIa of DENV-4 in the PhilippinesMark Anthony de Vera Luz, Takeshi Nabeshima, Meng Ling Moi, et al.
Virology|January 17, 2021
U.S.-Japan cooperative medical sciences program: 22nd International Conference on Emerging Infectious Diseases in the Pacific RimKristina T Lu, Takuya Yamamoto, David McDonald, et al.
Pageof 11